Best Practices in Diagnosis of IPF and PPF
Anna Podolanczuk, M.D., M.S., discusses how the differential diagnosis for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) is approached, the importance of early diagnosis and why these diseases are often misdiagnosed.
Video content above is prompted by the following:
- What is in your differential diagnosis when considering IPF and PPF, and how do you arrive at a diagnosis?
- Why is an early diagnosis of IPF and PPF so critical for patients, and why is this disease often misdiagnosed?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Examining Health Equity Among Different Racial and Ethnic Subpopulations With Multiple Sclerosis
March 15th 2021Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.
Read More
Improving Ophthalmic Care Access and Treatment Among Aging Adults
August 20th 2020As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.
Read More
